R. Coffman, A. Sher, and R. Seder, Vaccine Adjuvants: Putting Innate Immunity to Work, Immunity, vol.33, issue.4, pp.492-503, 2010.
DOI : 10.1016/j.immuni.2010.10.002

C. Pasare and R. Medzhitov, Control of B-cell responses by Toll-like receptors, Nature, vol.4, issue.7066, pp.364-368, 2005.
DOI : 10.1038/nature04267

T. Querec, R. Akondy, E. Lee, W. Cao, and H. Nakaya, Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans, Nature Immunology, vol.8, issue.1, pp.116-125, 2009.
DOI : 10.1038/ni.1688

T. Querec, S. Bennouna, S. Alkan, Y. Laouar, and K. Gorden, Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity, The Journal of Experimental Medicine, vol.77, issue.2, pp.413-424, 2006.
DOI : 10.1016/j.cub.2003.12.020

S. Kasturi, I. Skountzou, R. Albrecht, D. Koutsonanos, and T. Hua, Programming the magnitude and persistence of antibody responses with innate immunity, Nature, vol.64, issue.7335, pp.543-547, 2011.
DOI : 10.1038/nature09737

G. Napolitani, A. Rinaldi, F. Bertoni, F. Sallusto, and A. Lanzavecchia, Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1???polarizing program in dendritic cells, Nature Immunology, vol.266, issue.8, pp.769-776, 2005.
DOI : 10.1016/S0022-1759(98)00204-X

H. Bohnenkamp, K. Papazisis, J. Burchell, and J. Taylor-papadimitriou, Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type I responses, Cellular Immunology, vol.247, issue.2, pp.72-84, 2007.
DOI : 10.1016/j.cellimm.2007.07.008

S. Mä-kelä, O. ¨. , P. Julkunen, and I. , TLR ligands induce synergistic interferon-?? and interferon-??1 gene expression in human monocyte-derived dendritic cells, Molecular Immunology, vol.48, issue.4, pp.505-515, 2011.
DOI : 10.1016/j.molimm.2010.10.005

A. Bagchi, E. Herrup, H. Warren, J. Trigilio, and H. Shin, MyD88-Dependent and MyD88-Independent Pathways in Synergy, Priming, and Tolerance between TLR Agonists, The Journal of Immunology, vol.178, issue.2, pp.1164-1171, 2007.
DOI : 10.4049/jimmunol.178.2.1164

F. Hayashi, K. Smith, A. Ozinsky, T. Hawn, and E. Yi, The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5, Nature, vol.410, issue.6832, pp.1099-1103, 2001.
DOI : 10.1038/35074106

L. Franchi, A. Amer, M. Body-malapel, T. Kanneganti, and N. Ozoren, Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1?? in salmonella-infected macrophages, Nature Immunology, vol.160, issue.6, pp.576-582, 2006.
DOI : 10.1038/ni1346

E. Miao, C. Alpuche-aranda, M. Dors, A. Clark, and M. Bader, Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1?? via Ipaf, Nature Immunology, vol.48, issue.6, pp.569-575, 2006.
DOI : 10.1038/ni1344

T. Means, F. Hayashi, K. Smith, A. Aderem, and A. Luster, The Toll-Like Receptor 5 Stimulus Bacterial Flagellin Induces Maturation and Chemokine Production in Human Dendritic Cells, The Journal of Immunology, vol.170, issue.10, pp.5165-5175, 2003.
DOI : 10.4049/jimmunol.170.10.5165

S. Arimilli, J. Johnson, K. Clark, A. Graff, and M. Alexander-miller, Engineered Expression of the TLR5 Ligand Flagellin Enhances Paramyxovirus Activation of Human Dendritic Cell Function, Journal of Virology, vol.82, issue.22, pp.10975-10985, 2008.
DOI : 10.1128/JVI.01288-08

C. Tosch, M. Geist, C. Ledoux, C. Ziller-remi, and S. Paul, Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy, Cancer Gene Therapy, vol.176, issue.4, pp.310-319, 2009.
DOI : 10.1158/0008-5472.CAN-07-1025

M. Ahmed, S. Puckett, S. Arimilli, C. Braxton, and S. Mizel, Stimulation of Human Dendritic Cells by Wild-Type and M Protein Mutant Vesicular Stomatitis Viruses Engineered To Express Bacterial Flagellin, Journal of Virology, vol.84, issue.22, pp.12093-12098, 2010.
DOI : 10.1128/JVI.00406-10

J. Huleatt, A. Jacobs, J. Tang, P. Desai, and E. Kopp, Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity, Vaccine, vol.25, issue.4, pp.763-775, 2007.
DOI : 10.1016/j.vaccine.2006.08.013

J. Huleatt, V. Nakaar, P. Desai, Y. Huang, and D. Hewitt, Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin, Vaccine, vol.26, issue.2, pp.201-214, 2008.
DOI : 10.1016/j.vaccine.2007.10.062

W. Mcdonald, J. Huleatt, H. Foellmer, D. Hewitt, and J. Tang, A West Nile Virus Recombinant Protein Vaccine That Coactivates Innate and Adaptive Immunity, The Journal of Infectious Diseases, vol.195, issue.11, pp.1607-1617, 2007.
DOI : 10.1086/517613

URL : https://hal.archives-ouvertes.fr/hal-00165516

S. Applequist, E. Rollman, M. Wareing, M. Liden, and B. Rozell, Activation of Innate Immunity, Inflammation, and Potentiation of DNA Vaccination through Mammalian Expression of the TLR5 Agonist Flagellin, The Journal of Immunology, vol.175, issue.6, pp.3882-3891, 2005.
DOI : 10.4049/jimmunol.175.6.3882

B. Wang, F. Quan, S. Kang, J. Bozja, and I. Skountzou, Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses, Journal of Virology, vol.82, issue.23, pp.11813-11823, 2008.
DOI : 10.1128/JVI.01076-08

A. Didierlaurent, I. Ferrero, L. Otten, B. Dubois, and M. Reinhardt, Flagellin Promotes Myeloid Differentiation Factor 88-Dependent Development of Th2-Type Response, The Journal of Immunology, vol.172, issue.11, pp.6922-6930, 2004.
DOI : 10.4049/jimmunol.172.11.6922

C. Nempont, D. Cayet, M. Rumbo, C. Bompard, and V. Villeret, Deletion of Flagellin's Hypervariable Region Abrogates Antibody-Mediated Neutralization and Systemic Activation of TLR5-Dependent Immunity, The Journal of Immunology, vol.181, issue.3, pp.2036-2043, 2008.
DOI : 10.4049/jimmunol.181.3.2036

S. Mcsorley, B. Ehst, Y. Yu, and A. Gewirtz, Bacterial Flagellin Is an Effective Adjuvant for CD4+ T Cells In Vivo, The Journal of Immunology, vol.169, issue.7, pp.3914-3919, 2002.
DOI : 10.4049/jimmunol.169.7.3914

C. Cuadros, F. Lopez-hernandez, A. Dominguez, M. Mcclelland, and J. Lustgarten, Flagellin Fusion Proteins as Adjuvants or Vaccines Induce Specific Immune Responses, Infection and Immunity, vol.72, issue.5, pp.2810-2816, 2004.
DOI : 10.1128/IAI.72.5.2810-2816.2004

S. Mizel and J. Bates, Flagellin as an Adjuvant: Cellular Mechanisms and Potential, The Journal of Immunology, vol.185, issue.10, pp.5677-5682, 2010.
DOI : 10.4049/jimmunol.1002156

J. Bates, S. Uematsu, S. Akira, and S. Mizel, Direct Stimulation of tlr5+/+ CD11c+ Cells Is Necessary for the Adjuvant Activity of Flagellin, The Journal of Immunology, vol.182, issue.12, pp.7539-7547, 2009.
DOI : 10.4049/jimmunol.0804225

M. Vijay-kumar, F. Carvalho, J. Aitken, N. Fifadara, and A. Gewirtz, TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin, European Journal of Immunology, vol.117, issue.12, pp.3528-3534, 2010.
DOI : 10.1002/eji.201040421

C. Turley, R. Rupp, C. Johnson, D. Taylor, and J. Wolfson, Safety and immunogenicity of a recombinant M2e???flagellin influenza vaccine (STF2.4xM2e) in healthy adults, Vaccine, vol.29, issue.32, pp.5145-5152, 2011.
DOI : 10.1016/j.vaccine.2011.05.041

J. Treanor, D. Taylor, L. Tussey, C. Hay, and C. Nolan, Safety and immunogenicity of a recombinant hemagglutinin influenza???flagellin fusion vaccine (VAX125) in healthy young adults, Vaccine, vol.28, issue.52, pp.8268-8274, 2010.
DOI : 10.1016/j.vaccine.2010.10.009

D. Taylor, J. Treanor, C. Strout, C. Johnson, and T. Fitzgerald, Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza???flagellin fusion vaccine (VAX125, STF2.HA1 SI), Vaccine, vol.29, issue.31, pp.4897-4902, 2011.
DOI : 10.1016/j.vaccine.2011.05.001

H. Talbot, M. Rock, C. Johnson, L. Tussey, and U. Kavita, Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin, PLoS ONE, vol.279, issue.12, p.14442, 2010.
DOI : 10.1371/journal.pone.0014442.s002

E. Vassilieva, B. Wang, A. Vzorov, L. Wang, and Y. Wang, Enhanced Mucosal Immune Responses to HIV Virus-Like Particles Containing a Membrane-Anchored Adjuvant, mBio, vol.2, issue.1, pp.328-00310, 2011.
DOI : 10.1128/mBio.00328-10

A. Cunningham, M. Khan, J. Ball, K. Toellner, and K. Serre, Responses to the soluble flagellar protein FliC are Th2, while those to FliC onSalmonella are Th1, European Journal of Immunology, vol.185, issue.11, pp.2986-2995, 2004.
DOI : 10.1002/eji.200425403

O. Schulz, S. Diebold, M. Chen, T. Nä-slund, and M. Nolte, Toll-like receptor 3 promotes cross-priming to virus-infected cells, Nature, vol.164, issue.7028, pp.887-892, 2005.
DOI : 10.1038/nri888

URL : https://hal.archives-ouvertes.fr/hal-00165709

A. Pichlmair, R. Sousa, and C. , Innate Recognition of Viruses, Immunity, vol.27, issue.3, pp.370-383, 2007.
DOI : 10.1016/j.immuni.2007.08.012

O. Schulz, A. Pichlmair, J. Rehwinkel, N. Rogers, and D. Scheuner, Protein Kinase R Contributes to Immunity against Specific Viruses by Regulating Interferon mRNA Integrity, Cell Host & Microbe, vol.7, issue.5, pp.354-361, 2010.
DOI : 10.1016/j.chom.2010.04.007

I. Ventoso, M. Sanz, S. Molina, J. Berlanga, and L. Carrasco, Translational resistance of late alphavirus mRNA to eIF2?? phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR, Genes & Development, vol.20, issue.1, pp.87-100, 2006.
DOI : 10.1101/gad.357006

G. Barry, L. Breakwell, R. Fragkoudis, G. Attarzadeh-yazdi, and J. Rodriguez-andres, PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response, Journal of General Virology, vol.90, issue.6, pp.1382-1391, 2009.
DOI : 10.1099/vir.0.007336-0

A. Hidmark, G. Mcinerney, E. Nordström, I. Douagi, and K. Werner, Early Alpha/Beta Interferon Production by Myeloid Dendritic Cells in Response to UV-Inactivated Virus Requires Viral Entry and Interferon Regulatory Factor 3 but Not MyD88, Journal of Virology, vol.79, issue.16, pp.10376-10385, 2005.
DOI : 10.1128/JVI.79.16.10376-10385.2005

G. Glasgow, M. Mcgee, B. Sheahan, and G. Atkins, Death mechanisms in cultured cells infected by Semliki Forest virus., Journal of General Virology, vol.78, issue.7, pp.1559-1563, 1997.
DOI : 10.1099/0022-1317-78-7-1559

G. Barry, R. Fragkoudis, M. Ferguson, A. Lulla, and A. Merits, Semliki Forest Virus-Induced Endoplasmic Reticulum Stress Accelerates Apoptotic Death of Mammalian Cells, Journal of Virology, vol.84, issue.14, pp.7369-7377, 2010.
DOI : 10.1128/JVI.02310-09

A. Hidmark, E. Nordström, P. Dosenovic, M. Forsell, and P. Liljeström, Humoral Responses against Coimmunized Protein Antigen but Not against Alphavirus-Encoded Antigens Require Alpha/Beta Interferon Signaling, Journal of Virology, vol.80, issue.14, pp.7100-7110, 2006.
DOI : 10.1128/JVI.02579-05

J. Thompson, A. Whitmore, J. Konopka, M. Collier, and E. Richmond, Mucosal and systemic adjuvant activity of alphavirus replicon particles, Proceedings of the National Academy of Sciences, vol.103, issue.10, pp.3722-3727, 2006.
DOI : 10.1073/pnas.0600287103

C. Smerdou and P. Liljeström, Two-helper RNA system for production of recombinant Semliki forest virus particles, J Virol, vol.73, pp.1092-1098, 1999.

G. Karlsson and P. Liljestrom, Live Viral Vectors: Semliki Forest Virus, Methods Mol Med, vol.87, pp.69-82, 2003.
DOI : 10.1385/1-59259-399-2:69

E. Sjöberg, M. Suomalainen, and H. Garoff, A Significantly Improved Semliki Forest Virus Expression System Based on Translation Enhancer Segments from the Viral Capsid Gene, Bio/Technology, vol.5, issue.11, pp.1127-1131, 1994.
DOI : 10.1083/jcb.111.3.867

M. Ryan and J. Drew, Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein, EMBO J, vol.13, pp.928-933, 1994.

M. Donnelly, G. Luke, A. Mehrotra, X. Li, and L. Hughes, Analysis of the aphthovirus 2A/2B polyprotein ???cleavage??? mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ???skip???, Journal of General Virology, vol.82, issue.5, pp.1013-1025, 2001.
DOI : 10.1099/0022-1317-82-5-1013

M. Rumbo, F. Sierro, N. Debard, J. Kraehenbuhl, and D. Finke, Lymphotoxin ?? receptor signaling induces the chemokine CCL20 in intestinal epithelium, Gastroenterology, vol.127, issue.1, pp.213-223, 2004.
DOI : 10.1053/j.gastro.2004.04.018

S. Uematsu, M. Jang, N. Chevrier, Z. Guo, and Y. Kumagai, Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells, Nature Immunology, vol.170, issue.8, pp.868-874, 2006.
DOI : 10.1038/44593

K. Smith, E. Andersen-nissen, F. Hayashi, K. Strobe, and M. Bergman, Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility, Nature Immunology, vol.4, issue.12, pp.1247-1253, 2003.
DOI : 10.1038/ni1011

J. Thompson, A. Whitmore, H. Staats, and R. Johnston, The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines, Vaccine, vol.26, issue.39, pp.4998-5003, 2008.
DOI : 10.1016/j.vaccine.2008.07.011

X. Zhou, P. Berglund, H. Zhao, P. Liljeström, and M. Jondal, Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus., Proceedings of the National Academy of Sciences, vol.92, issue.7, pp.3009-3013, 1995.
DOI : 10.1073/pnas.92.7.3009

C. Sanders, L. Franchi, F. Yarovinsky, S. Uematsu, and S. Akira, Induction of adaptive immunity by flagellin does not require robust activation of innate immunity, European Journal of Immunology, vol.303, issue.2, pp.359-371, 2009.
DOI : 10.1002/eji.200838804

M. Sundbäck, I. Douagi, C. Dayaraj, M. Forsell, and E. Nordström, Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles, Virology, vol.341, issue.2, pp.190-202, 2005.
DOI : 10.1016/j.virol.2005.07.017

T. Nä-slund, C. Uyttenhove, E. Nordström, D. Colau, and G. Warnier, Comparative Prime-Boost Vaccinations Using Semliki Forest Virus, Adenovirus, and ALVAC Vectors Demonstrate Differences in the Generation of a Protective Central Memory CTL Response against the P815 Tumor, The Journal of Immunology, vol.178, issue.11, pp.6761-6769, 2007.
DOI : 10.4049/jimmunol.178.11.6761

F. Liu, Y. J. Zhang, Y. Zhou, D. Chen, and Y. , Recombinant flagellins with partial deletions of the hypervariable domain lose antigenicity but not mucosal adjuvancy, Biochemical and Biophysical Research Communications, vol.392, issue.4, pp.582-587, 2010.
DOI : 10.1016/j.bbrc.2010.01.077

T. Ben-yedidia and R. Arnon, Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine, Immunology Letters, vol.64, issue.1, pp.9-15, 1998.
DOI : 10.1016/S0165-2478(98)00073-X

A. Honko, N. Sriranganathan, C. Lees, and S. Mizel, Flagellin Is an Effective Adjuvant for Immunization against Lethal Respiratory Challenge with Yersinia pestis, Infection and Immunity, vol.74, issue.2, pp.1113-1120, 2006.
DOI : 10.1128/IAI.74.2.1113-1120.2006

J. Huber and J. Farrar, Regulation of effector and memory T-cell functions by type I interferon, Immunology, vol.33, issue.4, pp.466-474, 2011.
DOI : 10.1111/j.1365-2567.2011.03412.x

S. Fink and B. Cookson, Pyroptosis and host cell death responses during Salmonella infection, Cellular Microbiology, vol.165, issue.11, pp.2562-2570, 2007.
DOI : 10.1152/ajpgi.00273.2005

M. Vijay-kumar, C. Sanders, R. Taylor, A. Kumar, and J. Aitken, Deletion of TLR5 results in spontaneous colitis in mice, Journal of Clinical Investigation, vol.117, pp.3909-3921, 2007.
DOI : 10.1172/JCI33084